LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹166 Cr | ₹162 Cr | ₹136 Cr | ₹116 Cr | ₹113 Cr |
What is the latest Sundry Debtors ratio of LINCOLN PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹166 Cr |
| Mar2024 | ₹162 Cr |
| Mar2023 | ₹136 Cr |
| Mar2022 | ₹116 Cr |
| Mar2021 | ₹113 Cr |
How is Sundry Debtors of LINCOLN PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹166 Cr | 2.86 | |
| Mar2024 | ₹162 Cr | 18.66 | |
| Mar2023 | ₹136 Cr | 17.59 | |
| Mar2022 | ₹116 Cr | 2.29 | |
| Mar2021 | ₹113 Cr | - | |
Compare Sundry Debtors of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,250.1 Cr | -1.3% | 1.1% | 13.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -1.3% |
1.1% |
13.8% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses